pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioSpace·6h ago·1 min read
save

Trump nominates White House aide Heidi Overton as FDA commissioner

Aug 19, 2026·read at BioSpace ↗RegulatoryNeutral

President Donald Trump is reported to be selecting Deputy Director of the White House Domestic Policy Council Heidi Overton, a physician, to be the next FDA commissioner, pending Senate confirmation.

Overton holds a medical degree from the University of New Mexico, completed a general surgery residency at Johns Hopkins, and earned a PhD in clinical investigation from the Bloomberg School of Public Health. Before joining the White House, she was chief policy officer and vice chair for the Center for a Healthy America at the conservative think tank America First Policy Institute.

Analysts at BMO Capital Markets described the late summer nomination as a modest positive, noting that her credentials could help restore predictability and credibility to the agency’s drug review process, which has been strained by recent layoffs and controversial policies.

source

This writeup was produced by pharmadog from original reporting by BioSpace.

Original headline: “Trump picks White House aide Heidi Overton as FDA chief: Reports”

read at BioSpace ↗
1,100 words · retrieved 5h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.3PATH
drugs
Rare Disease2
topics
Rare Disease3AdComCRL (Complete Response Letter)Vaccines

related stories

  • 4h agoKolon TissueGene cuts 37 US staffers after Phase 3 failBioSpace
  • 5d agoCapricor soars on potential FDA review extension, filing amendmentsBioSpace
  • Aug 6Third time’s the charm for Replimune as melanoma drug earns FDA greenlightBioSpace
  • Aug 6Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he wasSTAT
  • Aug 6FDA approves Moderna’s mRNA flu vaccine, the first to use the technologySTAT